Next-Gen Biosafety Masterclass

Next Generation Sequencing (NGS) in Biosafety Testing: From Regulation to Routine Use

SEPTEMBER 10, 2026 in Paris (France)

Pathoquest is pleased to announce the upcoming Next-Gen Biosafety Masterclass: “Next Generation Sequencing (NGS) in Biosafety Testing: From Regulation to Routine Use.”

🗓️ September 10, 2026

🕣 Registration: 08:15–08:45 CEST
🗣️ Presentations: 09:00–17:00 CEST
🍸 Cocktail Reception: 17:00–18:00 CEST

📍 11 Rue Watt, BioPark, Bâtiment B, 75013 Paris, France

👤 IN-PERSON

A full day of expert insights — explore the agenda below:

08:15–08:45
Attendee Check-in
09:00–09:15
Welcome, Strategic Context & Presentation of the Agenda
Colette Côté – Executive Director & Scientific Advisor, Global Biologics Testing Services, Pathoquest
Horst Ruppach – Executive Director Scientific and Portfolio, Global Biologics, Charles River Laboratories
09:15–09:30
Biologics: Market Trends, Pipeline Dynamics, and Industrial Production
Elsa Kress – Head of Business Development, MabDesign
09:30–10:00
European Regulations on Detection of Viral Adventitious Agents by Next Generation Sequencing
Johannes Bluemel – Head of Viral Safety Section, Paul-Ehrlich-Institut
10:00–10:30
Global Overview of Implementation and Regulatory Acceptance of NGS for Vaccine Safety Testing
Laura Viviani – Founder and Consultant, SciEthiQ
10:30–11:00
☕ Coffee Break
11:00–11:30
Agency Expectations and the Use of NGS: Have They Finally Aligned?
Colette Côté – Executive Director & Scientific Advisor, Global Biologics Testing Services, PathoQuest
Horst Ruppach – Executive Director Scientific and Portfolio, Global Biologics, Charles River Laboratories
11:30–12:00
Characterization of Starting Materials for the Production of Virus Therapeutics by Next Generation Sequencing (NGS)
Michael Ruffing – Global Development CMC Biologicals, Boehringer Ingelheim
12:00–13:15
🍽️ Lunch & Optional Lab Tour
13:15–13:45
Integrated Use of Viromic and Transcriptomic NGS for Adventitious Virus Testing
Jens Modrof – Director Operations, Global Pathogen Safety, Takeda
13:45–14:15
The Power and Challenges of NGS in Viral Vector Identity Assays
Nadia Avenier – Head of Analytical Expertise Center, SK pharmteco
14:15–14:45
HTS for Adventitious Virus Detection: An Early Adoption with Strategic Choices to Support Sanofi New Vaccines Viral Safety
Carine Logvinoff – Virology Global Analytical Expert, Sanofi
14:45–15:15
Adoption of NGS for Viral Safety Testing in Exosome Manufacturing
Huilan Lin – Principal Scientist, Capricor Therapeutics
15:15–15:45
☕ Coffee Break
15:45–16:45
Ask the Experts – Interactive Session
All speakers
16:45–17:00
Key Takeaways
Colette Côté – Executive Director & Scientific Advisor, Global Biologics Testing Services, Pathoquest
Horst Ruppach – Executive Director Scientific and Portfolio, Global Biologics, Charles River Laboratories
17:00–18:00
🍸 Cocktail Reception & Optional Lab Tour